Regulation of induction of nitric oxide synthase and the inhibitory actions of dexamethasone in the human intestinal epithelial cell line, Caco-2: influence of cell differentiation

被引:32
作者
Cavicchi, M [1 ]
Whittle, BJR [1 ]
机构
[1] St Bartholomews & Royal London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England
关键词
Inducible nitric oxide synthase; iNOS; colonic epithelial cell line; Caco-2; differentiation; NF-kappa B; JAK-2; glucocorticoids; 1400; W;
D O I
10.1038/sj.bjp.0702827
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The inducible isoform of nitric oxide synthase (iNOS) may be involved in the pathogenesis of inflammatory bowel disease. Using the human intestinal epithelial cell. line, Caco-2, iNOS expression, regulation and sensitivity to the glucocorticoid, dexamethasone after cytokine exposure and its relationship to the degree of differentiation has been studied. 2 NOS activity, assessed by NO2- and NO3- release, was time-dependently increased after exposure to interferon gamma alone or in combination with interleukin-1 beta and tumour necrosis factor alpha. 3 Cytokine-induced iNOS activity was increased with days in culture over 20 days and number of passages, suggesting iNOS up-regulation during enterocyte-like differentiation. This activity was inhibited by the selective iNOS inhibitor 1400 W (0.1-100 mu M). In addition, iNOS protein induction was confirmed by Western blot. 4 Actinomycin D (5 mu g ml(-1)) inhibited cytokine-induced iNOS activity, protein expression and mRNA level. Pyrrolidine dithiocarbamate (PDTC: 10-200 mu M) and 3,4 dichloroisocoumarin (0.1-100 mu M) reduced cytokine-induced iNOS activity and protein expression at both day 10 and 15 after confluence. PDTC also decreased iNOS mRNA levels, suggesting NF-kappa B involvement in its transcription at these times. 5 The tyrphostins A25 and B42 reduced cytokine-induced iNOS activity at both day 10 and 15 after confluence, indicating the JAK-2 kinase is also involved at these times. The tyrphostins also reduced the iNOS protein expression. 6 Dexamethasone (0.1-10 mu M, for 24 h) reduced cytokine-induced iNOS activity at day 15 and 20 after cell confluence, but not at day 5 or 10. 7 Dexamethasone (5 mu M) decreased cytokine-induced iNOS protein expression at day 10 as well as at day 15 after confluence. 8 These findings indicate that iNOS induction and its inhibition by dexamethasone in this human intestinal epithelial cell line is dependent on the degree of differentiation.
引用
收藏
页码:705 / 715
页数:11
相关论文
共 50 条
[1]  
Ambs S, 1998, CANCER RES, V58, P334
[2]   Pro-inflammatory signaling:: Last pieces in the NF-κB puzzle [J].
Baeuerle, PA .
CURRENT BIOLOGY, 1998, 8 (01) :R19-R22
[3]   NITRIC-OXIDE SYNTHASE ACTIVITY IN ULCERATIVE-COLITIS AND CROHNS-DISEASE [J].
BOUGHTONSMITH, NK ;
EVANS, SM ;
HAWKEY, CJ ;
COLE, AT ;
BALSITIS, M ;
WHITTLE, BJR ;
MONCADA, S .
LANCET, 1993, 342 (8867) :338-340
[4]  
BriskeAnderson MJ, 1997, P SOC EXP BIOL MED, V214, P248
[5]   Suppression by dexamethasone of inducible nitric oxide synthase protein expression in vivo -: A possible role for lipocortin 1 [J].
Bryant, CE ;
Perretti, M ;
Flower, RJ .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (03) :279-285
[6]   HETEROGENEITY OF CANCER-CELLS FROM A SINGLE HUMAN-COLON CARCINOMA [J].
DEXTER, DL ;
SPREMULLI, EN ;
FLIGIEL, Z ;
BARBOSA, JA ;
VOGEL, R ;
VANVOORHEES, A ;
CALABRESI, P .
AMERICAN JOURNAL OF MEDICINE, 1981, 71 (06) :949-956
[7]   BILE-SALTS DETERMINE LEUKOTRIENE B-4 SYNTHESIS IN A HUMAN INTESTINAL-CELL LINE (CACO-2) [J].
DIAS, VC ;
SHAFFER, EA ;
WALLACE, JL ;
PARSONS, HG .
DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (04) :802-808
[8]   ISOFORMS OF NITRIC-OXIDE SYNTHASE - PROPERTIES, CELLULAR-DISTRIBUTION AND EXPRESSIONAL CONTROL [J].
FORSTERMANN, U ;
GATH, I ;
SCHWARZ, P ;
CLOSS, EI ;
KLEINERT, H .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (09) :1321-1332
[9]   CYTOKINES, ENDOTOXIN, AND GLUCOCORTICOIDS REGULATE THE EXPRESSION OF INDUCIBLE NITRIC-OXIDE SYNTHASE IN HEPATOCYTES [J].
GELLER, DA ;
NUSSLER, AK ;
DISILVIO, M ;
LOWENSTEIN, CJ ;
SHAPIRO, RA ;
WANG, SC ;
SIMMONS, RL ;
BILLIAR, TR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) :522-526
[10]   Drug therapy - Inflammatory bowel disease [J].
Hanauer, SB .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (13) :841-848